Table 1

Summary of historical landmark trials comparing rate vs. rhythm strategies in atrial fibrillation.

TrialRefNAge (years)Mean follow-upProportion in sinus rhythm (rate vs. rhythm)Stroke or systemic embolism
RateRhythm
PIAF (2000)1325261 ± 10110% vs. 56% at 1 year01.6
AFFIRM (2002)14406070 ± 93.535% vs. 63% at 5 years4.34.6
RACE (2002)1555268 ± 92.310% vs. 39% at 2.3 years2.76.0
STAF (2003)1620066 ± 81.611% vs. 26% at 2 years2.05.0
HOT CAFÉ (2004)1720561 ± 111.7NR vs. 64%1.02.9
J-RHYTHM (2009)1882364 ± 111.644% vs. 73% at 3 years3.02.4
TrialRefNAge (years)Mean follow-upProportion in sinus rhythm (rate vs. rhythm)Stroke or systemic embolism
RateRhythm
PIAF (2000)1325261 ± 10110% vs. 56% at 1 year01.6
AFFIRM (2002)14406070 ± 93.535% vs. 63% at 5 years4.34.6
RACE (2002)1555268 ± 92.310% vs. 39% at 2.3 years2.76.0
STAF (2003)1620066 ± 81.611% vs. 26% at 2 years2.05.0
HOT CAFÉ (2004)1720561 ± 111.7NR vs. 64%1.02.9
J-RHYTHM (2009)1882364 ± 111.644% vs. 73% at 3 years3.02.4

Adapted from Fuster et al.19

AFFIRM, Atrial Fibrillation Follow-Up Investigation of Rhythm Management; HOT CAFÉ, How to Treat Chronic Atrial Fibrillation; J-RHYTHM, Japanese Rhythm Management Trial for Atrial Fibrillation; NR, not reported; PIAF, Pharmacological Intervention in Atrial Fibrillation; RACE, Rate Control vs. Electrical Cardioversion for Persistent Atrial Fibrillation; STAF, Strategies of Treatment of Atrial Fibrillation.

Table 1

Summary of historical landmark trials comparing rate vs. rhythm strategies in atrial fibrillation.

TrialRefNAge (years)Mean follow-upProportion in sinus rhythm (rate vs. rhythm)Stroke or systemic embolism
RateRhythm
PIAF (2000)1325261 ± 10110% vs. 56% at 1 year01.6
AFFIRM (2002)14406070 ± 93.535% vs. 63% at 5 years4.34.6
RACE (2002)1555268 ± 92.310% vs. 39% at 2.3 years2.76.0
STAF (2003)1620066 ± 81.611% vs. 26% at 2 years2.05.0
HOT CAFÉ (2004)1720561 ± 111.7NR vs. 64%1.02.9
J-RHYTHM (2009)1882364 ± 111.644% vs. 73% at 3 years3.02.4
TrialRefNAge (years)Mean follow-upProportion in sinus rhythm (rate vs. rhythm)Stroke or systemic embolism
RateRhythm
PIAF (2000)1325261 ± 10110% vs. 56% at 1 year01.6
AFFIRM (2002)14406070 ± 93.535% vs. 63% at 5 years4.34.6
RACE (2002)1555268 ± 92.310% vs. 39% at 2.3 years2.76.0
STAF (2003)1620066 ± 81.611% vs. 26% at 2 years2.05.0
HOT CAFÉ (2004)1720561 ± 111.7NR vs. 64%1.02.9
J-RHYTHM (2009)1882364 ± 111.644% vs. 73% at 3 years3.02.4

Adapted from Fuster et al.19

AFFIRM, Atrial Fibrillation Follow-Up Investigation of Rhythm Management; HOT CAFÉ, How to Treat Chronic Atrial Fibrillation; J-RHYTHM, Japanese Rhythm Management Trial for Atrial Fibrillation; NR, not reported; PIAF, Pharmacological Intervention in Atrial Fibrillation; RACE, Rate Control vs. Electrical Cardioversion for Persistent Atrial Fibrillation; STAF, Strategies of Treatment of Atrial Fibrillation.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close